Related Experiment Video
Updated: Feb 1, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Improvement of hereditary palmoplantar keratoderma with oral trametinib
Hannah Song1,2, Fiatsogbe Dzuali1,2, Susan N Chi3
1Harvard Medical School, Boston, Massachusetts.
Insights
A child with congenital deafness, palmoplantar keratoderma (PPK), and hypothalamic glioma experienced significant PPK improvement with trametinib cancer therapy. The condition worsened upon drug withdrawal, suggesting trametinib
Area of Science:
- Oncology
- Dermatology
- Genetics
Background:
- Palmoplantar keratoderma (PPK) is a group of genetic skin disorders characterized by thickening of the palms and soles.
- The underlying molecular mechanisms of many PPK forms remain incompletely understood.
- Hypothalamic glioma is a rare brain tumor.
Observation:
- A child with congenital deafness, PPK, and hypothalamic glioma received trametinib for cancer treatment.
- The patient exhibited marked improvement in PPK during trametinib therapy.
- PPK severity increased upon trametinib withdrawal.
Findings:
- Trametinib therapy demonstrated a clear correlation with PPK improvement.
- The temporal relationship between trametinib use and PPK severity suggests a causal link.
- MAPK signaling pathway may play a role in the pathogenesis of PPK.
Implications:
- Trametinib may be a potential therapeutic agent for certain forms of PPK.
- Targeting the MAPK pathway could offer new treatment strategies for PPK.
- Further research is warranted to explore MEK inhibitors in dermatological conditions.
Abstract:
We report a child with a past medical history notable for congenital deafness, palmoplantar keratoderma (PPK), and hypothalamic glioma who initiated a MEK inhibitor trametinib for cancer-directed therapy at 11 years of age and was incidentally noted to have marked improvement in his PPK. Trametinib withdrawal led to worsening in the patient's PPK. We speculate that the patient's PPK improved because of trametinib, given the temporal relationship between trametinib therapy and PPK severity, observed both after introduction and withdrawal of trametinib therapy. The upregulation of MAPK signaling may be involved in the pathogenesis of keratinocyte proliferation in at least some forms of PPK, given that downstream inhibition of MAPK signaling led to an improvement in the patient's PPK.
Related Concept Videos
Oral Cavity
Teeth: The teeth are the hardest structures in our bodies. Humans have two sets of teeth throughout their lifetime: deciduous (baby) teeth and permanent teeth. Each tooth consists of several parts: the crown (visible part), the root (embedded in the jaw), enamel (hard outer...
Oral Hypoglycemic Agents: Glinides
Psychosexual Stages of Personality: Oral
Weaning, typically occurring...
Improving Translational Accuracy
Improving Translational Accuracy
Assessing Body Temperature - Oral
Step 1:
Start by practicing proper hand hygiene to prevent the spread of microorganisms.
Step 2:
Take the thermometer out of the charging unit, switch it on, and wait for the ready sign.
Step 3:
Gently slide the probe cover until a click is heard. This simple action prevents cross-contamination and ensures the correct placement of the probe cover.
Step 4:
Instruct the patient to open their mouth and place...

